In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity - Wikidata - awgldk - TriplyDB

In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity

In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity

http://www.wikidata.org/entity/Q36868792

about

Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.Cytokine-induced NK-like T cells: from bench to bedside.NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects.IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor.Arming cytokine-induced killer cells with chimeric antigen receptors: CD28 outperforms combined CD28-OX40 "super-stimulation".Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease.CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD HDAC inhibition and graft versus host disease Cisplatin pretreatment enhances anti-tumor activity of cytokine-induced killer cells.Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation Immunotherapy for hepatocellular carcinoma: From basic research to clinical use.Treatment of CD33-directed chimeric antigen receptor-modified T cells in one patient with relapsed and refractory acute myeloid leukemia.NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.The therapeutic effect of cytokine-induced killer cells on pancreatic cancer enhanced by dendritic cells pulsed with K-ras mutant peptide Donor colonic CD103+ dendritic cells determine the severity of acute graft-versus-host disease.Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells.Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.Cytokine-induced killer (CIK) cells: from basic research to clinical translation.Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model.Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion.Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma Cytokine-induced killer cell therapy for the treatment of primary hepatocellular carcinoma subsequent to liver transplantation: A case report Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer.Targeting deacetylases to improve outcomes after allogeneic bone marrow transplantation.IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells.NaHCO3 enhances the antitumor activities of cytokine-induced killer cells against hepatocellular carcinoma HepG2 cells Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation.Early efficacy of stereotactic body radiation therapy combined with adoptive immunotherapy for advanced malignancies Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform.In vivo proof of concept of adoptive immunotherapy for hepatocellular carcinoma using allogeneic suicide gene-modified killer cells.New perspectives on the biology of acute GVHD.Manipulating the expression of chemokine receptors enhances delivery and activity of cytokine-induced killer cells.Host bone marrow-derived IL-12 enhances donor T cell engraftment in a mouse model of bone marrow transplantation.Immunoregulation of GVHD by triggering the innate immune system with CpG.Mouse models of graft-versus-host disease: advances and limitations

P2860

Q33429758-7E91C970-5F4E-4DA9-A8FE-66C0514D06D0 Q33762499-D75EE46E-47AA-49EB-8376-5A49294A35CE Q33887452-BE7F4B92-6A97-456A-B130-6F28E9E954B7 Q34077847-B0EEE7C8-D6A2-40E5-A0D7-5123E8A7A1C1 Q34329186-0BA1DC49-D3E7-476C-A1DA-065FDA9818E9 Q34367252-732AC469-3C59-4317-9870-72D9AD777113 Q34568892-351B5944-C086-4A6C-AB44-93204E21BA48 Q34707286-85F2139A-4290-4642-8B90-2E9F1C4E2B41 Q35016985-C6E4D4ED-C7E9-4979-9A38-1A2B8C673F41 Q35093618-28F679D8-63E1-472D-97ED-C3077B08D015 Q35218943-55B39938-34EF-439C-80CA-493248AF3DB1 Q35567765-A17712FA-5E6C-4A15-8719-676D42D46B32 Q35591409-D4816F3D-9415-4C71-B510-BB6D0CC1D7EA Q35692428-206CA505-B0E6-4DC7-9813-131AB2C2AD60 Q35733767-FA95A491-364F-47C0-83B1-D140FF8A292F Q35755295-54014CED-6471-49B8-AF67-9F5CBD423232 Q35894369-DDD25E73-C06E-454F-BF2E-BA6BE0ED6AAE Q36057599-D8850194-A8A5-4F5B-8B97-84A7F1718F2E Q36106330-7ED6117C-0712-4179-8DD6-9D0A02500D9A Q36121153-AF2A1008-B336-46AC-AD94-FFCE78602CE0 Q36137504-DE6B5AFF-735B-49A9-913A-8D29C94D8BDB Q36351988-4C14D8DA-81AB-4DE8-A497-0DB41D7A0C88 Q36380188-F3C9C72A-E933-4F45-98A1-9F3166B00CD8 Q36566943-40ED9105-1347-4E9A-863F-733D563E85C2 Q36571270-76E7AF81-B13C-4283-A8EB-51A60231ED21 Q36640769-50680B3C-CF54-4011-A1A9-5E3C396B8B5E Q36962962-7DFAF45F-7154-4BE5-949E-9EDDEEC9A1D6 Q37026059-6F76F1E1-0A58-4420-B415-67CC6A302F6B Q37041732-02D92E60-4E31-44FD-A777-2BE3BB089461 Q37084335-B940B155-BDA9-4CD1-90A7-DD02FCFA715F Q37406855-5E14982B-8A58-43BD-968F-101E825C5AAE Q37492611-14E4824F-ADCE-4341-A212-62EB9B18DB50 Q37560863-61CCC107-E2C5-4AC4-9E9C-05A4EFB539E9 Q37588329-41B489F6-5672-4DC7-801B-A96EE7AFDA26 Q37620831-B6373283-1817-4585-99D3-E25AE3D75437 Q37641063-4D6D06E5-0A8F-4EBE-B7F7-AF06FC6499FB Q37711663-F306A4CD-D1FF-4AE9-AF67-04BF712AB19B Q37717313-F85EAA82-6DD1-4EFC-9D72-53A0E8EAA2F7 Q37810081-B86E3BD0-4D16-42F3-9282-8CE0B70ECC93 Q37874011-64DEC93F-66B9-47DB-B7B9-35D50C584DC5

P2860

In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity

http://www.wikidata.org/entity/Q36868792

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

In vivo trafficking and surviv ...... etention of antitumor activity

@en

type

label

In vivo trafficking and surviv ...... etention of antitumor activity

@en

prefLabel

In vivo trafficking and surviv ...... etention of antitumor activity

@en

P1433

Q36868792-02B4E0C3-CED7-4B40-9D9C-A61C213FECA4

P1476

Q36868792-1E4974EE-A92D-4C7B-BD57-96E9DB8D33E3

P2093

Q36868792-0B36AFBD-9785-47F2-B7BD-071DA628C9FE

Q36868792-40D1AA4A-FB51-4901-BEE2-45C84B517DE6

Q36868792-58CA4F2F-517B-4AFF-A038-B54214C49F43

Q36868792-5E4C94C3-91F9-49B2-808E-F596397B30C2

Q36868792-9CF7359F-9860-4475-81C7-586DB5D05840

Q36868792-AE963C95-283B-4F79-BB1C-51BF110B4B86

Q36868792-E63E2278-B8CC-4767-B9BA-A467DF371B53

Q36868792-FC744F61-4BB4-45CF-89F0-07A0B704EE17

P2860

Q36868792-0FB053A8-9174-4415-A6EF-9423A8FD953F

Q36868792-1E11004A-5CDF-423F-83C5-DC8CED87DBE2

Q36868792-20040359-3AD4-45B9-93B1-32BAD450778A

Q36868792-226E10FD-7E3B-412F-BE99-C3BBD1DDECCD

Q36868792-22CF66EB-A8A0-49E1-9D47-358A714C0BF1

Q36868792-39CC150B-43CE-4FED-83F8-031D20BB78D0

Q36868792-3F5C1195-B564-4EC8-9332-818CDB2CE48E

Q36868792-63DBBC83-C7C7-4C37-BE3D-67C89026C0CD

Q36868792-71EBD866-E17F-4DF4-943E-99961746D225

Q36868792-72E4E570-0809-4734-9076-23149C3F25C4

P304

Q36868792-186259AE-ACC3-4DFA-854F-94B4550B9D5F

P31

Q36868792-299BB2FD-D9C6-4DF9-B7E5-0B424C19DF6F

P356

Q36868792-8E340525-12DF-4A3C-8138-E8599A83D930

P407

Q36868792-B6FF4F68-6428-4603-9B61-505724350522

P433

Q36868792-2DDF90DD-B92D-415A-9322-C35C4460528D

P478

Q36868792-F56ED9C5-CE9E-4706-8D25-92987175E515

P577

Q36868792-3DC27DEE-4112-4354-AD2F-27087D617C5C

P5875

Q36868792-A4524ED4-94AB-4F46-948C-CA56CD65540E

P698

Q36868792-69D4D876-36B6-4B4F-A0F3-A07C04CDE28D

P932

Q36868792-105D4DFA-7CC5-442D-A2D1-FB2F062896D8

P356

BLOOD-2007-06-092817

P1433

P1476

In vivo trafficking and surviv ...... etention of antitumor activity

@en

P2093

Andreas Beilhack

http://www.w3.org/2001/XMLSchema#string

Emanuela I Sega

http://www.w3.org/2001/XMLSchema#string

Janelle A Olson

http://www.w3.org/2001/XMLSchema#string

Jeanette Baker

http://www.w3.org/2001/XMLSchema#string

Mobin Karimi

http://www.w3.org/2001/XMLSchema#string

Robert S Negrin

http://www.w3.org/2001/XMLSchema#string

Robert Zeiser

http://www.w3.org/2001/XMLSchema#string

Ryosei Nishimura

http://www.w3.org/2001/XMLSchema#string

P2860

Control of regulatory T cell development by the transcription factor Foxp3

Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.

Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.

Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study.

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.

Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.

Shifting foci of hematopoiesis during reconstitution from single stem cells

In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets

Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine

Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance.

P304

2563-2574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2007-06-092817

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5290487

http://www.w3.org/2001/XMLSchema#string

P698

18565854

http://www.w3.org/2001/XMLSchema#string

P932

2532819

http://www.w3.org/2001/XMLSchema#string